EditorialPublished 23 Apr 2020
Pharma Sci-The Role of ABC Efflux Transporter in Treatment of Pharmaco-Resistant Schizophrenia: A Review Article- Alemayehu D- Ambo University
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction Schizophrenia is a chronic and disabling brain disease and serious mental disorder with an annual incidence of 0.23 per 1000 persons and a prevalence rate over life of around 1% . The effectiveness of drug treatments for Central Nervous System (CNS) disorders (epilepsy, depression, and schizophrenia) is limited by poor therapeutic outcomes or drug resistance might due insufficient drug enter brain. This makes up to 12.9%-50% of schizophrenic patients are pharmaco-resistant schizophrenia. That is why the issues of efficacy and safety of antipsychotic drugs are still far from having idealistic values. Even though the causes of pharmaco-resistant schizophrenia are likely to be multifactorial, the ABC drug efflux transporter Pglycoprotein (P-gp) expressed at the blood-brain barrier, in particular, might play an important role. The brain uptake of the majority of antipsychotics, as well as many other psychotropic drugs and endogenous compounds is hampered by the activity of P-glycoprotein. Moreover, acting alone or in concert with drug metabolizing enzymes they can affect the pharmacokinetics and pharmacodynamics of antipsychotic drugs. However, randomized controlled studies on these issues with psychotropic drugs, in particular antipsychotic in humans are still lacking. To achieve efficacy, pharmaco-resistant schizophrenia frequently requires increased doses or an increase in the number of drugs administered which can often result in toxic drug-drug interactions and unwanted physiological side effect. This current review focuses on the functional significance of membrane transporters as drug carriers: as their role is constantly increasing in current medical practice and as they represent a key factor in clinical outcome. It elaborately assesses the impact of efflux transporter, mainly P-gp, its polymorphism and its modulation on the drug therapy of schizophrenia, while the other ABC transporters were briefly reviewed. We used different searching terms like ABC transporters, efflux transporter, P-gp, MDR1 protein, ABCB1, Multi drug resistant associated proteins, MRP1, ABCC1, Breast cancer resistance proteins, BCRP, ABCG2, MRP2, ABCC2, Polymorphism of P-gp, P-gp substrate, anti-psychotic agents, pharmaco-resistant schizophrenia, P-gp modulator and P-gp inhibitor from searching engine like Medline, Pubmed and Google scholar. ABC efflux transporter The ABC (ATPbinding cassette) transporters constitute one of the largest super families of membrane proteins. They are ubiquitous in all phyla Drug transporters are those proteins that carry either endogenous compounds like electrolytes, nucleosides, amino acids, and glucose or xenobiotics across the biological membranes. These play an important role in the uptake, bioavailability, efficacy, toxicity and clearance of drugs. Drug transporters are membrane proteins present in various tissues such as the lymphocytes, intestine, liver, kidney, testis, placenta, and central nervous system.
Keywords
Subjects
Pharmaceutical SciencesConferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacological Reviews and Reports
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Alemayehu D”
